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he risk of suicide climbs dramatically in old age
in most industrialized nations, with the highest rates
found among the very old and especially among men.
1 In
the US,the suicide rate in white men aged 80 to 84 years
is more than 5 times higher that in the total population.
2
This paper describes the methodology of PROSPECT
(Prevention of Suicide in Primary Care Elderly:Collab-
orative Trial), an intervention study modeled on the
premise that the most effective approach to deterring a
rare but devastating event like late-life suicide is in elim-
inating its primary risk factor: depression. PROSPECT
tests an intervention designed to facilitate “on-time,on-
target”treatment for late-life depression in primary care
patients. The intervention's effect is evaluated using a
longitudinal study design that integrates population-
based methodology with clinically sensitive assessment
in patients from 18 diverse primary care practices.
The following pages first describe the logic behind
PROSPECT’s aims and methodology. A major focus of
this first section is identifying targets of a suicide preven-
tion intervention.The second section describes the inter-
vention being tested byPROSPECT and the methodology
being used to investigate the impact of the intervention on
suicide risk.
The problem: suicide in late life
Identifying targets for intervention research
As the ninth leading cause of death among developed
nations,suicide is a major public health problem.
3A sub-
stantial amount of research in recent years, conducted
Suicide is a major public health problem with great-
est risk in the very old. This paper describes an
approach to reducing the risk of suicide by inter-
vening on depression in elderly primary care
patients. Depression is an appropriate target for an
intervention as it is highly prevalent in primary care,
is a strong risk factor for suicide, and is more often
than not inadequately treated. PROSPECT (Preven-
tion of Suicide in Primary Care Elderly: Collabora-
tive Trial) is a National Institute of Mental Health
(NIMH)–funded collaborative study that is testing
this approach to suicide risk prevention in 18 pri-
mary care practices in the United States. PROSPECT’s
intervention of “guideline management” introduces
a health specialist into the primary care setting to
help physicians provide “on-time, on-target” treat-
ment and long-term management of late-life
depression following structured clinical guidelines.
The effectiveness of the intervention in reducing
suicidal risk and depression is evaluated by following
a representative sample of older patients identified
using a 2-stage design.
T
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from a number of academic vantage points, has coa-
lesced to identify a variety of risk factors and correlates
of suicide in late life.
4 These findings make it possible
to develop and test suicide prevention strategies.A first
step is to investigate whether there are subgroups of the
population who are at very high risk,for whom focused
intervention strategies are most needed and might have
their greatest impact.In the case of suicide risk preven-
tion, the extraordinarily high rates of suicide in the
elderly justify designing an intervention for this group.
The next step is to identify an appropriate target for
the prevention intervention. A useful strategy is to
identify a risk factor that is common,strongly related to
suicide risk, and is, in and of itself, malleable.The epi-
demiologic notion of “population-attributable risk”
(PAR) may be useful to this argument.The PAR is an
estimate of the proportion of all cases (eg,suicide) in a
population than can be ascribed to a particular risk
factor.
5The PAR is a compound measure reflecting the
relative risk and the frequency (prevalence) of the fac-
tor in the population.A factor may incur a very large
risk for suicide, but be so rare in the target population
that even a highly effective intervention-targeting con-
dition may do little to reduce the overall rate of suicide
in the population. Conversely, a significant risk factor
for suicide may be very prevalent in the population
(eg,living alone),but be so weakly associated with sui-
cide risk that a successful intervention will also do little
to reduce the overall rate of suicide in the population.
Successfully intervening on a factor that both strongly
affects the risk of suicide and occurs in a large number
of individuals would potentially reduce the overall sui-
cide rates in the target population.
An effective public health suicide prevention strategy
needs to identify a risk factor that is not only highly
prevalent and strongly associated with suicide,but also
changeable.Old age,male gender,living alone,widow-
hood, and other sociodemographic factors associated
with suicide are difficult, if not impossible, to modify,
making them inappropriate intervention targets
(although, as noted above, potentially useful ways to
narrow target populations). Depression, other psychi-
atric disorders, and access to firearms or other lethal
methods are risk factors for suicide that are potentially
amenable to change and thus potentially appropriate
targets for an suicide prevention intervention.The pur-
pose of intervention studies is to investigate both the
extent to which the intervention does modify the risk
factor and then whether changing the risk factor
changes the outcome of interest.While the methodol-
ogy for choosing a risk factor to target for an interven-
tion draws heavily from epidemiologic and other obser-
vational sciences, the design of the intervention is
informed by a wide range of sources, including natu-
ralistic and controlled treatment studies as well as a
wide range of other human, social, or organizational
experiments.
Selecting depression in late life
PROSPECT aims to intervene on depression as a way of
reducing the risk of suicide in late life because depres-
sion meets all three criteria for an intervention target:
depression is strongly associated with the risk of suicide;
late-life depression is relatively pervasive,ranging from
1% to 10% among community-dwelling elderly; and
effective treatments for depression exist,but are not yet
used adequately in the majority of cases of late-life
depression.The following paragraphs elaborate on each
of these points.
Several types of evidence point to depression in late
life as a both potent and prevalent risk factor for suicide
in late life. First, longitudinal studies of depressed psy-
chiatric patients report suicide rates far higher than
those in the general population. An estimated 6% to
15% of psychiatric patients with major depression die
by suicide.
6 A 1-year follow-up study of psychiatric reg-
ister cases observed that depressed patients aged 55
years or older had more than twice the rate of suicide
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SSRIs selective serotonin reuptake inhibitors(475/100 000) than younger depressed patients (207/
100 000).
7A second type of data implicating depression
as a risk factor for suicide comes from studies of suicidal
behavior,including attempted suicide and other suicidal
gestures. Although suicidal behavior does not always
result in a completed suicide, it remains a very strong
predictor of future completed suicides.
8 A study of a
large population of patients in a health insurance group
reported a suicide rate close to 5 times higher for
patients with depression than the population rate. A
third type of study reconstructs the psychological pro-
files of suicide victims. These psychological autopsy
studies have found depression to be the most common
psychiatric diagnosis in elderly suicide victims.
9,10 One
study of elderly suicide victims noted that 76% had
diagnosable psychopathology and, of these, 54% had
major depression and 11% had minor depression.
9
Another psychological autopsy study confirmed that
depression is the most likely psychiatric diagnosis in
elderly suicide victims.
10
Major depression and other forms of depressive symp-
tomatology are highly prevalent in elderly primary care
patients.
11 In general,the estimated prevalence of major
depression—measured with both semistructured and
structured interviews—in geriatric samples of primary
care range between 6% and 9%.
12,13 A substantial pro-
portion of the remaining elderly primary care patients
report minor depression or other forms of subsyndromal
depressive symptomatology. Minor depression is rele-
vant to the study of suicide,in part because psychologi-
cal autopsy studies of suicide victims report that depres-
sion in these cases was more often mild or moderate
than severe.Older patients who report suicidal ideation
have also been found to be depressed, but they are not
always severely depressed or functionally impaired.
14 In
addition, minor and other forms of subsyndromal
depression have been associated with a variety of other
adverse outcomes in older adults.
15,16
Important to the choice of depression as an approach to
suicide prevention is that depression in late life is treat-
able. Both pharmacological and psychotherapeutic
approaches have demonstrated efficacy in the treatment
of depression in late life. The introduction of selective
serotonin reuptake inhibitors (SSRIs) has greatly
enhanced the effectiveness of medication treatment
because these drugs are safer and easier to administer
than classic antidepressants. Randomized studies of
SSRIs have included approximately 700 depressed
elderly patients treated with fluoxetine,450 with parox-
etine, and 400 with sertraline.
17 Even when these drugs
are not tolerated, their side effects consist of subjective
discomfort rather than significant health risk to the
patient. The safety in routine use and overdose,
18 and
simplicity of administration of SSRIs,allow these agents
to be used by nonspecialized physicians. SSRIs may be
particularly effective in mild-to-moderate depression,
19
which constitutes the majority of cases of elderly sui-
cide victims.In addition to pharmacotherapy,a variety of
psychotherapies,including interpersonal therapy (IPT),
cognitive-behavioral therapy (CBT), problem-solving
therapy, and perhaps psychodynamic psychotherapies,
also have demonstrated effectiveness in the acute treat-
ment of depressed elderly outpatients.
20
Equally relevant as acute treatment to suicide preven-
tion may be the perspective of depression as a recur-
rent, chronic illness so that even when patients recover
from an episode of depression the risk of recurrence is
high. Like other chronic illnesses, strategies to monitor
and maintain recovery may be essential to ongoing pre-
vention of suicide risk.
Selecting the intervention setting: primary care 
Primary care is an ideal setting for an intervention
aimed at reducing the risk of suicide in the elderly pop-
ulation.As noted, the prevalence of depression is sub-
stantially higher in primary care patients than the gen-
eral elderly population. Moreover, 88% of US
residents above age 65 have visited a doctor’s office
within the past year.
21 Most important,70% or more of
elderly suicide victims were seen by their primary care
physician within a month before their death.
1,4 Thus,
primary care clinicians are positioned to intervene on
very-high-risk patients.
Primary care is also an ideal target for intervention
because depression is not being treated as well as it
might be in primary care.Despite evidence that depres-
sion is prevalent and that treatments for depression are
efficacious in primary care,late-life depression remains
both underdiagnosed and undertreated in primary care
settings.In mixed-age medical populations,only approx-
imately 40% of depressed patients are identified by their
physicians.
22,23 Any number of factors can contribute to
underrecognition of depression in primary care.
Older patients may hold attitudes, or interpret their
sensations or feelings, such that they are less likely to
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102report having the affective or ideation symptoms of
depression. Compared with younger groups, older
adults are less likely to report the affective symptoms
of depression.
24,25 Instead, older adults are more likely
to ascribe symptoms of depression to a physical ill-
ness.
26,27 Studies in the UK
28 have also found that
patients may misunderstand treatments for depression
(eg, believe that antidepressants are addictive), and
therefore be less forthcoming with symptom reports
to avoid treatments.
Schulberg and McClelland
29 reported a number of
physician factors related to failure to recognize
depression across a variety of patients.These included
a lack of knowledge of the symptoms and manage-
ment of depression, a focus on possible organic
pathology, failure to elicit relevant affective, cogni-
tive, or somatic symptoms, and underrating of the
severity of depressive symptoms. A common reason
for depression to be misdiagnosed in primary care
settings may be the frequently held assumption that
the syndrome is a “natural” consequence of aging and
its associated challenges. Shao and her associates
recently reported on attitudes about depression
among faculty physicians who were generalists (gen-
eral medicine internists and family physicians) or non-
generalists (medicine subspecialists and obstetricians-
gynecologists), as well as psychiatrists.
30 Over 90% of
nongeneralists thought depression was understand-
able given the patient’s medical and social situation—
an attitude that posts a significant barrier to treat-
ment particularly in the elderly.
31 Avoidance of
stigmatization on the part of physicians also con-
tributes to underdetection of depression. A signifi-
cant proportion of primary care physicians report that
they have intentionally avoided diagnosing a mood
disorder even when recognized, in order to avoid
stigmatizing the patient.
32
Even when diagnosed, depression is inadequately
treated in primary care, despite the availability of effi-
cacious treatments for depression and guidelines for
using these treatments.Studies suggest that both physi-
cians and patients contribute to this problem.Approxi-
mately 11% of depressed high utilizers of primary care
services receive adequate antidepressant treatment,
while 34% received inadequate treatment and 55%
received no treatment.
33 In a study of a large primary
care practice, only 41% of patients identified by the
physicians as depressed received any antidepressant
treatment regardless of age and medical comorbidity.
34
In four Pittsburgh primary care centers, primary care
physicians who were informed of depression diagnoses
failed to provide any treatment to 27% of depressed
patients.
35 When physicians did prescribe antidepres-
sants, the prescriptions were of insufficient dosage and
duration.Inadequate treatment can result not only from
underprescribing, but also from lack of treatment
adherence by the patient.
36 Meta-analysis of medication
use studies showed a 35% nonadherence rate for anti-
depressant medication.
37 Poor treatment adherence is




A case study, modeled after a real event, may help to
illustrate some common features making depression
in late life in primary care an appropriate target for
intervention.
An elderly individual, typically a man (we will call him
Mr Smith), is a 78-year-old widower, formerly a small
business owner,who has lived alone since his wife died 4
years ago.He has an extensive medical history including
pyloric stenosis, chronic obstructive pulmonary disease,
and prostate and bladder cancer. Six weeks ago, Mr
Smith underwent extensive abdominal and bladder
surgery. Since returning home, Mr Smith has “given up
hope on everything.” He is no longer interested in read-
ing, TV, or playing cards with his friends. He wishes he
could sleep better but spends much of the night awake,
worrying about his health and ruminating about his past.
During the day, he eats sporadically, and finds himself
too tired and lethargic to keep his home tidy. A proud
man,he views his messy house,like his decaying body,as
symbolic of how little his life is now valued.He wonders
daily whether he should kill himself and, if he did, who
would care. He has decided that if he does kill himself,
the best way is with a gun. He has a rifle, left over from
his hunting days, that he keeps in the bedroom closet.
The ammunition is in a desk drawer.
Mr Smith is somewhat ashamed of these thoughts and
keeps most of them to himself.At his doctor’s visit, Mr
Smith mentions only that he is having trouble sleep-
ing and eating and feels a little lethargic. His physician
responds that a loss of energy is normal given Mr
Smith's age, his health problems, and the stress he has
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103experienced. He is concerned about Mr Smith's
appetite, however, and orders additional diagnostic
tests.At home that night, Mr Smith lies in the dark envi-
sioning an endless set of painful tests and procedures
leading to nowhere but death. In the morning, he takes
the gun down from the shelf and loads it with ammu-
nition. It sits on the desk for a week, always beckoning
as an easier alternative to doing and being nothing.
One night, Mr Smith writes a final note to his sons and
ends his life.
Perhaps the most important feature of this fictional
case is that depression remains unrecognized by the
patient and the primary care physician who provides
the patient's care. In part, symptoms of sadness, so
predominant in younger cases of depression, are not
present, but instead the patient conveys anhedonia
or lack of interest in previously pleasurable activi-
ties coupled with reduced functioning in areas of per-
sonal and social responsibilities. Other symptoms are
somatic and, given competing medical illnesses, may
not be linked to the other symptoms of depression, so
that the physician may miss the diagnosis. In part,
these other comorbid illnesses take priority in the
demands of the primary care physician’s time. Finally,
depression remains a stigmatized condition in the
eyes of many older adults, so that the patient denies
depression, making the problem of recognition and
treatment even more difficult. Finally, the primary
care physician did not routinely screen for potential
means of suicide, for example, guns, other weapons,
or overstocked medications.
In the case study, neither the patient nor the physician
recognized the depression. Other scenarios are possi-
ble.The physician may recognize depression,but believe
that treating it is less important than addressing the
other medical problems. The physician may diagnose
depression,but prescribe a subadequate dose of antide-
pressant. The physician may diagnose and recommend
treatment, but have little time to discuss the issue with
the patient who then refuses treatment.The patient may
initiate treatment, but experience side effects and stop
treatment before symptoms remit. Or, the patient may
initiate treatment, but stop once symptoms begin to
diminish and relapse not long after.For each scenario,an
effective intervention would increase the likelihood of
successful treatment of the patient’s depression and
reduction of suicide risk.
PROSPECT 
Overview
The Prevention of Suicide in Primary Care Elderly:Col-
laborative Trial (PROSPECT) is a multisite study
funded by the National Institute of Mental Health
(NIMH) to test a model of depression recognition and
treatment aimed at preventing and reducing suicidal
behavior in older primary care patients. The study is a
collaboration among the NIMH Intervention Research
Centers (IRCs) of Cornell University, University of
Pennsylvania,and University of Pittsburgh.
The collaborative model brings a number of advantages to
the study, not the least of which is that it allows the study
to draw on the wealth of experience and expertise from
each center. As will be described below, the intervention
attempts to effect meaningful clinical outcomes in a rep-
resentative patient sample by changing the organization
of care.The study design, therefore, necessarily integrates
expertise and methodologies from multiple disciplines,
ranging from treatment-focused clinical research to popu-
lation-based epidemiology and services research.
The tasks needed to accomplish this study are shared
among the three IRCs. Each IRC has three specific
roles: contributing to the overall design and structure
of the study, conducting the intervention in local pri-
mary care practices, and coordinating, with input from
the other IRCs,the functions of a specific methodologi-
cal core: Research Design and Assessments (Cornell),
Intervention Development (Pittsburgh),and Data Man-
agement and Analysis (Pennsylvania). The Cornell
group is responsible for overall coordination, including
the integration of the three primary functions and the
comparability of study implementation across the three
centers and their primary care sites.
The multisite collaboration also helps recruit and fol-
low a big enough study population from a large enough
number of primary care practices so that the findings 
of  PROSPECT will have broad generalizability.
As described in more detail below,the study is collecting
longitudinal data from approximately 1380 patients from
18 different primary care practices, most of which are
not affiliated with an academic institution, and which
range greatly in size and proximity to urban centers.The
sociodemographic characteristics of the patient popula-
tions served by these practices also vary, including sev-
eral populations that are more than 50% racial or ethnic
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sentative sample of older patients, including an over-
sample of the very old,from which patients with mild-to-
severe depression are identified,recruited,and followed
prospectively.
Aims
The primary aims of PROSPECT are to test the fol-
lowing in a representative sample of older patients in
primary care practices:
•The effectiveness of its proposed intervention in pre-
venting and reducing suicidal ideation, hopelessness,
and depression.
•The impact of the intervention on the initiation of treat-
ment and outcomes (depression,disability,medical mor-
bidity, cognitive dysfunction) in those patients whose
characteristics place them at high risk for suicide.
•The effectiveness of the intervention in preventing and
reducing sequelae or complications of depression asso-
ciated with suicidal behavior, including substance
abuse,sleep disturbances,pain,and disability in elderly
patients with degressive signs and symptoms.
PROSPECT's intervention
PROSPECT’s “guideline management” intervention
implements procedures in primary care practices
designed to facilitate the use of a comprehensive treat-
ment algorithm for depression based on the Agency for
Health Care Policy and Research (AHCPR) guidelines.
In designing the intervention,the investigators drew not
only from their clinical research,but also from the inter-
vention studies for depression in mixed-aged or older
primary care patients as well as studies of other chronic
conditions of late life.The resulting intervention reflects
several current trends in primary care practice:(i) using
practice guidelines and/or critical pathways to guide
treatment decisions; (ii) adding physician extenders for
disease-specific case management (such as an anticoag-
ulation nurse-specialist or diabetes nurse); and (iii)
strengthening patient compliance with treatment regi-
mens through patient and family education strategies.
These components and their rationale are described in
the following paragraphs.
PROSPECT's intervention begins with an algorithm
for treating late-life depression in primary care settings
through the acute, continuation, and maintenance
phases. The algorithm draws heavily on the AHCPR
practice guidelines for treating depression in primary
care. PROSPECT investigators modified these guide-
lines by tailoring them for specific use in the elderly
(eg, providing dosages for older patients) and by rec-
ommending a preferred sequence of treatment choices.
Sequencing treatment choices reduces the heterogene-
ity in the kinds of specific treatments patients receive,
while retaining the locus of treatment decisions with
the physician, not the study. An important feature of
the PROSPECT algorithm is that it is comprehensive,
providing procedures for both the typical case and the
atypical.At each step of the algorithm,physicians have
the option of obtaining a consultation in psychiatry or
referring a patient to a specialist with the expectation
that upon completion of specialty care the patient will
return to primary care.
The PROSPECT treatment algorithm recommends anti-
depressant therapy as first-line treatment with citalo-
pram as the drug of choice. Citalopram was chosen
because it is equally efficacious as other SSRIs and has
an advantageous side-effect profile in use with the
elderly. The study will provide citalopram to patients
when prescribed by their physician.Physicians can con-
sider other antidepressants if citalopram is contraindi-
cated. If a patient does not want any antidepressant
medication therapy, the physician can recommend psy-
chotherapy. For the purposes of the study, the
PROSPECT guideline recommends interpersonal ther-
apy (IPT) and the study will provide IPT to patients for
whom it is recommended.
It may be helpful to reiterate that the purpose of
PROSPECT is not to test whether or not citalopram
and IPT are efficacious in treating depression in elderly
primary care patients. These therapies were chosen
because evidence already indicates that they can be
effective under ideal conditions.Rather,the challenge of
PROSPECT is to facilitate the efficacious use of these
treatments under less than ideal conditions. Part of the
goal is to ensure that physicians use these treatments in
a recommended fashion. Research has also shown that
when primary care physicians do follow practice guide-
lines,their use can positively influence both the process
of care (93% of 59 studies) and clinical outcomes of care
(81% of 11 studies).
39 Under normal circumstances,how-
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105ever, physicians are slow to adopt practice guidelines.
Adoption of depression guidelines may face even
greater barriers than guidelines for other conditions, as
depression remains a stigmatized condition,especially in
older cohorts. Thus, physicians can feel uncomfortable
about giving their patients a diagnosis of depression and
patients and family may not want to acknowledge one.
Further, depression is not a focus of most primary care
physicians’ training, so that some physicians consider it
of secondary importance. Finally, comorbid medical ill-
ness, functional disability, and cognitive decline often
complicate the diagnosis and treatment of depression
and place competing demands on the physician and can
make it more difficult for the patient to follow recom-
mended treatment.
Controlled studies of the impact of different strategies to
change physician behavior consistently indicate that tra-
ditional educational methods (eg,printed materials,lec-
ture-style conferences) alone have little sustained impact
on either physician behavior or patient outcomes.
40,41 In
part, traditional educational methods are too general;
generic information is removed from a specific patient's
needs at a given time.
42 Coupled with the lack of speci-
ficity are the growing time demands on primary care
practice that interfere with their ability to obtain the
information needed to use the guidelines effectively.
Time constraints have been specifically identified as a
significant barrier to their treating depressed patients
adequately.
43
Approaches that most influenced physician adherence
to practice guidelines employed patient-specific reminders
or prompts at the time of consultation,thereby facilitat-
ing “on-time, on-target” treatment. The linchpin of the
PROSPECT intervention is the addition of a health
specialist (eg,nurse,social worker,or clinical psycholo-
gist) to the primary care setting who can obtain needed
information from patients (symptoms, comorbid con-
ditions, side effects, and treatment adherence) and to
use this information in prompting physicians with on-
time and on-target recommendations about appropriate
care for their patients.The health specialist collaborates
with the physicians by helping them recognize depres-
sion, offering timely and appropriately targeted treat-
ment recommendations based on the treatment guide-
lines, monitoring the clinical status of patients, and
encouraging patients to adhere to treatment.Additional
procedures aim at educating patients, families, and
physicians on depression and suicidal ideation. The
approach is expected to lead to a reduction of depres-
sive symptomatology and suicidal ideation and behavior
in elderly primary care patients and to generate a prac-
tice model that has the ability to incorporate the
advances of our clinical science.
An advantage of the health specialist is that the role
combines the necessary “prompt” to the primary care
physician about the timing of decisions in an algorithm
of care (a task that has also been given to computers)
with a way of extending the physician's ability to man-
age the treatment of depression over time. This use of
physician extenders is a growing trend in primary care
for the treatment management of other chronic illnesses,
where, for example, an anticoagulation nurse-specialist
or diabetes nurse spends time with the patient and fam-
ily teaching them about the disease and its treatment
and monitoring compliance with treatment and side
effects.This approach integrates two other models that
have been tested in primary care settings to improve
the recognition and treatment of suicidal ideation or
depression.Katon's intervention
44,45 was based on a col-
laborative model in which depressed mixed-aged
patients were treated by both their primary care physi-
cian and a psychiatrist.On 4-month follow-up,the inter-
vention led to greater decrease in depressive symptoms
and signs than placebo in patients with major depres-
sion, but not minor depression. Nonetheless, the inter-
vention improved medication compliance and satisfac-
tion with care in all patients. A different approach
provided physician treatment guidelines for their pri-
mary care patients with depression.
46 Consistent with
the general literature on guideline adaptation,physician
education alone resulted in greater recognition of
depression, but not adequate treatment among those
identified as depressed.
PROSPECT's guideline management intervention,like
the physician-focused model, targets physician and
patient adherence to treatment guidelines.Like the col-
laborative model,a specialist is integrated into the pri-
mary care setting, but in this case the specialist has the
task of collaborating with the physician and increasing
recognition of depression and adherence to specific
treatment guidelines. An advantage of the guideline
management model for elderly patients is that it is
expected to increase both the acceptability to patients
and usefulness to practices. In studies of primary care
patients, the vast majority of depressed patients report
preferring to receive help for emotional distress by their
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specialist.
47 Further, when primary care patients are
referred to mental health specialists, as many as half
do not reach the specialist.
48,49These findings in mixed-
age groups might be even stronger in an elderly popu-
lation as community studies report more negative atti-
tudes towards mental health specialists among older
than younger adults.
50 From the physician’s perspec-
tive, guideline management keeps control of patient
treatment in the hands of the primary care physician.
As the majority of primary care physicians prefer
treating their depressed patients themselves rather
than referring them to others,
43 this approach is
expected to be more acceptable to physicians,which if
found feasible, increases the likelihood of its being
adopted into general practice.
The difference between an intervention that facili-
tates the use of a guideline to identify and treat
depression rather than prescribes the treatment for
patients enrolled in the study is analogous to the dif-
ference within controlled treatment trials in analyses
of intent-to-treat patients compared with treated
patients. PROSPECT aims to test the effect of the
intervention on reducing suicide risk in a sample of all
practice patients, not just those who following the
steps of the treatment algorithm. The analysis, how-
ever, will need to examine the extent to which the pri-
mary care physicians did adhere to the guideline’s
recommendations and the fidelity of the health spe-
cialist to the intervention prescribed by the interven-
tion. So, while the PROSPECT investigators have
attempted to package in its intervention elements
chosen to optimize the efficacy of treatment, its
acceptability to patients, and usefulness to physicians,
the possibility remains that the overwhelming time
constraints faced by modern primary care and the
unshakable stigma attached to depression will con-
tinue to undermine effective care. Conversely, to the
extent that the PROSPECT intervention is successful,
the study will have sufficient data to develop and then
test hypotheses about the most critical components.
Primary care sites
To evaluate the impact of its intervention on patient out-
comes, PROSPECT is collecting data from 18 separate
primary care practices from 3 geographic areas (metro-
politan and outlying New York, Philadelphia, and Pitts-
burgh). Practices were selected in pairs sharing similar
characteristics in terms of academic affiliation, location
(urban,suburban,or rural),size (number of physicians),
and the race/ethnicity of the patients.All practices serve
both managed-care and fee-for-service patients.As seen
in Table I, the 9 pairs of practices represent considerable
diversity including both academic and nonacademic
urban practices,a wide range in patient racial/ethnic com-
position,including both academic and nonacademic prac-
tices with greater than 50% minority patients,and solo as
well as large group practices.
The generalizability of PROSPECT findings to primary
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Location Number of Practice Practice Number of physicians Minority
practices location affiliation per practice patients (%)
Cornell 
2 Urban Academic 44-48 50-60
2 Suburban Private 4-6 10-15
2 Suburban Private 1 5
Pennsylvania
2 Urban Private 1-3 83-86
2 Urban Private 5-6 58-86
2 Suburban Private 3 2 - 8
Pittsburgh
2 Urban Academic 9 21
2 Suburban Private 5-7 2
2 Rural Private 3-10 5-10
Table I. Characteristics of PROSPECT physician practices (n=18).
107care throughout the United States is limited to some
extent by the fact that practices were not randomly
selected and are all located in the northeast.On the other
hand,the heterogeneous characteristics of the recruited
practices and their patients do extend the representative
of PROSPECT findings beyond much previous research
that was limited to academic-affiliated settings,predom-
inately white patients, or single locations. In the United
States,the vast majority (74%) of elderly adults live in a
metropolitan area (1990 Census),
51 lending further gen-
eralizability to findings from the study.
Within each pair, practices were randomly selected to
receive the guideline management intervention or
“enhanced care,” a less intense intervention consisting
primarily of physician education and depression identi-
fication.Although acknowledging that identification of
depression is an important part of clinical care,
PROSPECT is not designed to evaluate different meth-
ods of identifying depression in primary care, for sev-
eral reasons. First, previous research has shown that
identification of depression in primary care alone has
little effect on patient outcomes. Second, in order to
evaluate the effect of the proposed intervention on
patient outcomes, comparable assessment is needed in
both intervention and usual care patients, necessitating
integrating assessment into the research protocol.And
third,for ethical reasons,physicians in both groups need
to be informed of the results of these assessments,mak-
ing a test of identification of depression by physicians
nonfeasible in the context of the current study.
The decision to randomize by practice rather than by
the individual physician or patient reflects several con-
siderations. Most important is the nature of the inter-
vention itself. As described above, the intervention
involves the placement of a specialist into a practice to
help physicians follow treatment guidelines. Although
the study might require the specialist not to directly con-
tact nonintervention patients if patients were random-
ized within a single practice,it is a likely—indeed hoped
for—outcome of the study that the experience of the
physician in working with the specialist in the long-term
treatment of depression with intervention patients will
“spill over” and affect the physician’s care of his or her
patients.Another option would be to randomize physi-
cians within a single practice.This strategy might work if
the physicians worked largely independently from each
other, but, especially in smaller practices, the threat of
contamination seems high.Potential bias resulting from
contamination in either scenario would dilute any effect
of the intervention and be very difficult to correct in the
analysis.In contrast,randomizing practices leads to two
biases that are resolvable at the analysis stage: (i) bias
created by treating the patient as the unit of analysis
while the practice is the unit of randomization; and (ii)
indication or selection bias rising from patient treatment
that is not blinded to the diagnosis of depression. Both
types of potential bias can be addressed using data-ana-
lytic strategies, the former by using random effects for
patients and practices and the latter using instrumental
variable modeling.
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A strength of PROSPECT is the involvement of sev-
eral primary care practices with no prior history of aca-
demic research.The willingness of the physicians to par-
ticipate is all the more noteworthy given the increased
time demands on them and their staff in the past few
years.These constraints pose an additional challenge to
studies such as PROSPECT trying to fit literally into
the office space and schedule. PROSPECT investiga-
tors have worked closely with the physicians, adminis-
trators, and office managers at each practice tailoring
procedures to minimize office burden while facilitating
access to data and space needed for the study method-
ology described below. At all practices, physicians met
with investigators to review procedures, approve the
PROSPECT patient recruitment letter, and receive a
packet of baseline physician assessments.A separate in-
service training was held for office support staff to
review study procedures and discuss strategies for
responding to patient phone calls concerning the study.
Patients
To study the effect of the intervention,PROSPECT col-
lects longitudinal data on patients both from practices in
which the guideline management intervention is imple-
mented and the comparison enhanced care practices.
Essential to PROSPECT’s aims is the test of the inter-
vention on patients who are representative of the pri-
mary care practice’s total active patient population,not
just patients who volunteer for the study or who are
identified as needing treatment by practice physicians.
Application of the public health model to intervention
research is an essential ingredient differentiating clinical
trials that test the efficacy of a treatment within a care-
fully chosen set of patients from studies of intervention
effectiveness in more representative samples.Treatments
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effectiveness for a variety of reasons, many deriving
from characteristics of the patient as well as factors
about the clinician. Of particular relevance to
PROSPECT,patient volunteers are likely to differ from
patients who do not volunteer by the severity of depres-
sion,coexisting medical illness,or functional disability,or
attitudes and beliefs about mental health problems and
their treatments,all factors that have been shown to also
affect treatment initiation,adherence,and response
53,54—
that is, the likelihood that a patient might benefit from
the intervention PROSPECT offers.
These patient selector factors may also affect primary
care physician behavior. For example, patients with
comorbid medical illness can pose greater difficulties in
diagnosing depression, be less willing to acknowledge
or discuss depressive symptoms, impose greater con-
straints on physician time.There is also a tendency for
clinicians to undervalue the severity of depression and
its impact on quality of life in older age. Finally, there
may be problems in diagnosis associated with cognitive
decline and medical comorbidity,and patient and family
unwillingness to be treated or to adhere to treatment.
To obtain its representative sample,PROSPECT uses a strati-
fied,2-stage design aimed to include an oversample of very
old subjects (over 75 years) as well as a disproportional
number of patients with depressive symptoms.The key is
being able to generalize back to the full practice popula-
tion.A small number of patients without depressive symp-
toms are entered into the study both to accommodate the
possibility of false negatives inherent in any screen and to
investigate the intervention's effect on prevention and early
detection of depression.
The sampling frame employed by PROSPECT is the
weekly appointment system.PROSPECT investigators
decided to select a sample of patients with scheduled
upcoming appointments because this is the group for
whom identification and treatment is most relevant in a
primary care practice. Depression in patients who do
not visit their doctors will not, by virtue of their
absence, come to the attention of primary care physi-
cians.The sampling frame also omits patients who make
urgent visits to the practice on the rationale that inter-
vention activities are not designed for use during emer-
gency care, so that patients who show up for unsched-
uled visits are not appropriate for inclusion into the
study at that time.Emergency patients who are at high
risk for suicidal ideation or depression will, in most
cases, be enrolled in the study through screening pro-
cedures conducted during a scheduled follow-up visit.
To keep the study as generalizable as possible, exclu-
sion criteria are few. Eligible patients are community-
dwelling (ie,do not live in a nursing home or other insti-
tution),age 60 and over,cognitively intact (evidenced by
a score >17 on the Mini-Mental State Examination),
able to give informed consent, and English-speaking.
The study is limited to English-speaking patients both
because opening the study to monolingual speakers of
other languages would greatly increase the cost and
complexity of providing intervention and research
assessments and because the ability of English-speak-
ing physicians to identify and treat depression in patients
who do not speak English is likely compromised. If
PROSPECT's intervention is successful,a next step will
be extending the intervention to patients who do not
speak English.
Over a period of 2 years,PROSPECT investigators will
receive on a weekly basis the schedule of upcoming
appointments.At each of the 3 study centers,the names
and ages are entered into the study's administrative
database. The computer identifies potentially eligible
patients, including patients who meet the age criteria
and have not already been sampled. As suicide risk is
greatest in the oldest ages, but the number of patients
declines with age,the oldest patients are oversampled by
randomly selecting patients within age strata (60 to 74
and 75+ years).The primary care practice mails a letter
to sampled patients informing them of the study and
giving them an opportunity to refuse contact. Patients
who do not refuse are screened for possible depression
by telephone using the Centers for Epidemiologic Stud-
ies Depression (CESD) scale.
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A large number of patients need to be screened by the
CESD in order to recruit approximately the final sample
of 1380 patients who will be followed longitudinally by
the study.The actual screening number will depend upon
the results of the screen and the willingness of patients
to participate in the longitudinal study. Using a conser-
vative estimate of participation rates, the study is pre-
pared to screen 11500 patients (6500 aged 60 to 74,5000
aged 75 and over) with the CESD screen across the 18
primary care sites. While screening patients over the
phone,their responses are scored directly into the com-
puter, which calculates the total score and identifies
which patients should be recruited into the study.Based
on previous work
56 on the screening properties of the
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Disorders  4th ed (DSM-IV) major depression, all
patients who score >20 on the CESD are recruited.As
discussed above, a small sample (5%) of patients who
score lower than 21 on the CESD are also recruited into
the study. The computer keeps track of each patient's
probability of selection at each stage of the sampling
process for the purpose of investigating the generaliz-
ability of the study's sample to the primary care practice
patient population as a whole.For example,at the com-
pletion of the study the investigators can calculate sam-
pling weights for the purpose of estimating practice-
based prevalence rates.
Patients who agree to recruitment are met at the prac-
tice for an in-person interview by research staff at a time
proximate to the scheduled office visit.The purpose of
this visit is to conduct, once informed consent is
obtained,a rigorous assessment of depression as well as
other clinical, neuropsychological, and social variables
needed for the analyses of course and outcome of
depression and suicide risk. In developing its research
assessment battery, PROSPECT investigators had to
balance the need for in-depth measures that adequately
capture the complex interaction among depression,med-
ical comorbidity, cognitive impairment, disability, lack
of social support in the primary care population with
the time,and other constraints of the primary setting.
Major and minor depressions are diagnosed with DSM-
IV criteria using the Structured Clinical Interview for
DSM-IV Diagnoses.
57 As noted when describing the
intervention above,if a patient from an intervention site
meets diagnostic criteria, the research staff informs the
intervention’s health specialist who will review the
patient’s chart,contact the physician with guideline rec-
ommendations,and otherwise initiate intervention pro-
cedures. In both intervention and enhanced care prac-
tices,information on any patient with evidence of suicide
risk will be reported immediately to the primary care
physician and a clinical investigator of the study.
PROSPECT has formalized procedures for evaluating
and addressing suicide risk in patients.
PROSPECT plans to recruit and follow 1380 patients
(780 aged 60 to 74, 600 aged 75 and over). Approxi-
mately two thirds of these patients will be treated for
major depression or minor depression,with most of the
remainder having significant depressive symptomatol-
ogy.An estimated 18% of the patients will report signif-
icant suicidal ideation at the time of their baseline inter-
view. All recruited patients, in both intervention and
enhanced care practices and regardless of diagnosis,are
recontacted for brief telephone assessments at 4 and 8
months following their baseline interview to track
depressive symptoms, suicide ideation, and health care
utilization.The full assessment battery is readministered
at two annual in-person follow-up interviews. Other
sources of patient data include information drawn from
medication and utilization records and death certificates
if applicable.
Conclusions
Suicide behavior is a significant public health problem
that is linked strongly to depression in late life. In the
elderly,the prevalence rate of depression is substantial,
yet rates of detection and treatment are far from ade-
quate. Untreated depression has significant conse-
quences with regard to suicide, as well as other sources
of morbidity and mortality. Although suicide is a rela-
tively low base rate behavior,a substantial proportion of
late-life suicides have contact with primary care
providers, offering an avenue of suicide prevention.
PROSPECT will test whether the provision of adequate
detection and treatment of depression in the primary
care setting will reduce precursors to suicidal behavior,
such as suicide ideation,hopelessness,and depression.If
the PROSPECT intervention proves effective, this
model of care holds promise for advancing the science
and practice of treating late-life depression and the pre-
vention of suicide.❏
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Esquema de intervención para prevenir el
suicidio: PROSPECT (Prevention of Suicide
in Primary Care Elderly: Collaborative Trial)
(prevención del suicidio en personas de
edad avanzada en atención primaria)
El suicidio es un problema creciente de salud pública
por el alto riesgo en personas de edad avanzada. El
presente artículo describe un enfoque terapéutico a fin
de reducir el riesgo de suicidio mediante el tratamiento
de la depresión de los sujetos de edad avanzada a nivel
de la atención primaria. Combatir la depresión es un
objectivo adecuado de la atención primaria,por la alta
prevalencia que allí se observa, porque es un factor de
riesgo importante de suicidio y porque se la trata
inadecuadamente.PROSPECT (Prevention of Suicide
in Primary Care Elderly: Collaborative Trial)
(Prevención del suicido en personas de edad avanzada
en atención primaria) es un estudio realizado en
colaboración con el National Institute of Mental Health
(NIMH) que examina este enfoque terapéutico de
prevención del riesgo de suicidio en 18 unidades de
atención primaria en los Estados Unidos. La
intervención de PROSPECT que contiene “directrices
tratamiento” introduce a un especialista en la atención
primaria a fin de ayudar a los médicos generales a
aplicar una terapéutica “a tiempo y de acuerdo a
objectivos perseguidos”y un tratamiento a largo plazo
de la depresión de comienzo tardío, cumpliendo
directrices clínicas estrucuradas. La eficacia de la
intervención en la reducción del riesgo de suicidio y
depresión es evaluada siguiendo una muestra
representativa de los pacientes de edad avanzada
identificados por utilizar un esquema en dos etapas.
Elaboration d’une stratégie pour
prévenir le suicide: PROSPECT
(Prevention of Suicide in Primary Care
Elderly : Collaborative Trial)
Le suicide constitue un problème majeur de santé
publique et son risque s’avère particulièrement élevé
chez le sujet trés âgé.Cet article décrit une approche qui
vise à réduire le risque suicidaire en intervenant sur la
dépression du sujet âgé dans le cadre de la médecine
générale. La dépression est une cible interventionnelle
appropriée : sa prévalence est élevée en médecine
générale et, de plus, elle constitue un facteur de risque
suicidaire majeur qui est plus souvent mal que bien
traité. L’étude PROSPECT (Prevention of Suicide in
Primary Care Elderly :Collaborative Trial) est un essai
multicentrique, mené sous l’égide du NIMH (National
Institute of Mental Health. Son objectif est d’évaluer
une telle approche du risque suicidaire dans 18 centres
de soins primaires, implantés aux Etats-Unis. La stra-
tégie PROSPECT repose sur une liste structurée de
recommandations cliniques mises en place par un spé-
cialiste,qui sur la base de celle-ci,agit au sein du centre
de soins en aidant les praticiens à choisir au bon
moment le traitement et la prise en charge au long cours
qui sont les mieux adaptés à la dépression du sujet âgé.
L’efficacité d’une telle intervention dans la réduction
du risque suicidaire et le contrôle de la dépression sera
évaluée en suivant un échantillon représentatif de sujets
âgés au moyen d’un plan en deux étapes.
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